Joan E. Booth

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial

Clopidogrel with or without Omeprazole in Coronary Artery Disease

Universal Definition of Myocardial Infarction

Relation Between Obesity and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies

Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease

Implications of Diabetes in Patients With Acute Coronary Syndromes<subtitle>The Global Registry of Acute Coronary Events</subtitle>

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Sex Differences in Native-Valve Infective Endocarditis in a Single Tertiary-Care Hospital

Spinal-cord injury

Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Enhanced external counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes

Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial

Platelet-Active Drugs

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis

Drug-eluting stents in vascular intervention

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Outcomes of repeat revascularization in diabetic patients with prior coronary surgery

Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

Unstable Angina Pectoris

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

Body Mass Index, Periprocedural Bleeding, and Outcome Following Percutaneous Coronary Intervention (from the British Columbia Cardiac Registry)

Late coronary stent thrombosis: Early vs. late stent thrombosis in the stent era

Normal Body Mass Index Rather than Obesity Predicts Greater Mortality in Elderly People: The Jerusalem Longitudinal Study

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Timing of Peak Troponin T and Creatine Kinase-MB Elevations After Percutaneous Coronary Intervention

Benefit of an Early Invasive Management Strategy in Women With Acute Coronary Syndromes

Race: Predictor versus proxy variable? Outcomes after spinal cord injury

Coronary Artery Stents

Platelet Activation and Atherothrombosis

Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories

The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome

Is early invasive treatment of unstable coronary artery disease equally effective for both women and men?

Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade

Heparin-Induced Thrombocytopenia

Diabetes and Atherosclerosis

Impact of weight on long-term survival among patients without known coronary artery disease and a normal stress SPECT MPI

Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study

The obesity paradox in non–ST-segment elevation acute coronary syndromes: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative

Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention

Guidelines for Percutaneous Coronary Interventions

Meta-Analysis of Randomized Trials of Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Peri-procedural myocardial injury: 2005 update

V_alue of First Day Angiography/Angioplasty I_n Evolving N_on-ST Segment Elevation Myocardial Infarction: An O_pen Multicenter Randomized Trial. The VINO Study

Myocardial Reperfusion Injury

Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction

The influence of optimal medical treatment on the ‘obesity paradox’, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study

Third Universal Definition of Myocardial Infarction

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction

Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events

Reporting of Noninferiority and Equivalence Randomized Trials

Abciximab

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention

Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin

Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention

Women and Ischemic Heart Disease

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT

Platelet-Active Drugs

Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects

Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization<SUBTITLE>REPLACE-2 Randomized Trial</SUBTITLE>

A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology

Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Glycoprotein IIb/IIIa Receptor Blockade Improves Outcomes in Diabetic Patients Presenting With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Periprocedural Myocardial Infarction

Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities

Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events

Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients

Baseline troponin level: key to understanding the importance of post-PCI troponin elevations

Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel

Inflammation and Atherosclerosis

Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

Defining the Optimal Activated Clotting Time During Percutaneous Coronary Intervention

Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂

Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes

Novel Platelet Inhibitors

Clinical Significance of Thrombocytopenia During a Non–ST-Elevation Acute Coronary Syndrome

The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting

Anti-GPIIb/IIIa Drugs: Current Strategies and Future Directions

Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)

Clinical Aspects of Platelet Inhibitors and Thrombus Formation

mice: Multivariate Imputation by Chained Equations inR

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

Clinical End Points in Coronary Stent Trials

Relationship Between Activated Clotting Time and Ischemic or Hemorrhagic Complications

Patient–physician gender concordance and increased mortality among female heart attack patients

Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients

Clinical Implications of Percutaneous Coronary Intervention-Clopidogrel in Unstable angina to prevent Recurrent Events (PCI-CURE) Study

Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus

Diabetes and Vascular Disease

The Coronary ArteryRevascularisation in Diabetes (CARDia) trial: Background, aims, and design

Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Clinical Features and Outcomes of Women With Unstable Ischemic Heart Disease

Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Principles From Clinical Trials Relevant to Clinical Practice: Part I

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Differences between men and women in the management of unstable angina pectoris (the Guarantee Registry)

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials

Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE registry

Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry

Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender

Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition

Optimizing the Percutaneous Interventional Outcomes for Patients With Diabetes Mellitus

Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab